JS004 Combined With Toripalimab and With Standard Chemotherapy Treat Patients With Advanced Lung Cancer

NCT05664971 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

119

Enrollment

OTHER

Sponsor class

Conditions

Advanced Lung Cancer

Interventions

BIOLOGICAL: Recombinant humanized anti-BTLA monoclonal antibody (JS004) injection
BIOLOGICAL: Toripalimab
DRUG: Docetaxel
DRUG: Pemetrexed
DRUG: Cisplatin
DRUG: Carboplatin
DRUG: Paclitaxel
DRUG: Etoposide

Sponsor

Shanghai Junshi Bioscience Co., Ltd.